In the intricate world of pharmaceutical manufacturing, the precise selection of chemical intermediates can dictate the success and efficacy of a final drug product. Among these crucial compounds, (1R,2R)-1,2-cyclohexanedicarboxylic acid stands out as a key chiral building block. Identified by its CAS number 46022-05-3, this molecule plays an indispensable role, particularly in the synthesis of Lurasidone, a significant antipsychotic medication used to treat schizophrenia and bipolar depression.

The importance of (1R,2R)-1,2-cyclohexanedicarboxylic acid stems from its specific stereochemistry. In pharmaceuticals, the spatial arrangement of atoms within a molecule can dramatically affect its interaction with biological targets. For drugs like Lurasidone, which have multiple chiral centers, using enantiomerically pure intermediates such as (1R,2R)-1,2-cyclohexanedicarboxylic acid is essential to ensure the correct three-dimensional structure is achieved. This precise structure is fundamental for the drug's intended pharmacological activity and to minimize potential side effects.

NINGBO INNO PHARMCHEM CO.,LTD. recognizes the critical nature of this compound and ensures its availability to support the pharmaceutical industry. The reliable supply of high purity cyclohexanedicarboxylic acid is a cornerstone for manufacturers aiming to produce high-quality Lurasidone. This intermediate allows for more efficient and stereoselective synthetic pathways, reducing the complexity and cost associated with resolving racemic mixtures later in the production process.

Furthermore, beyond its established role in Lurasidone production, (1R,2R)-1,2-cyclohexanedicarboxylic acid serves as a versatile chiral synthon in broader organic chemistry applications. Its functional groups offer numerous possibilities for further chemical modification, making it a valuable asset for researchers developing novel chemical entities or exploring new synthetic methodologies. Understanding the chemical properties of CAS 46022-05-3 is key for chemists seeking to leverage its potential in various innovative projects.

For companies looking to secure a dependable source for this vital pharmaceutical intermediate, NINGBO INNO PHARMCHEM CO.,LTD. provides access to top-tier quality materials. The consistent availability of such specialized building blocks is a testament to the sophisticated supply chains that underpin modern medicine. By prioritizing the use of well-defined intermediates like (1R,2R)-1,2-cyclohexanedicarboxylic acid, pharmaceutical manufacturers can continue to bring life-changing treatments to patients worldwide.